Growth monitoring: a survey of current practices of primary care paediatricians in Europe

PLoS One. 2013 Aug 5;8(8):e70871. doi: 10.1371/journal.pone.0070871. Print 2013.

Abstract

Objective: We aimed to study current practices in growth monitoring by European primary care paediatricians and to explore their perceived needs in this field.

Methods: We developed a cross-sectional, anonymous on-line survey and contacted primary care paediatricians listed in national directories in the 18 European countries with a confederation of primary care paediatricians. Paediatricians participated in the survey between April and September 2011.

Results: Of the 1,198 paediatricians from 11 European countries (response rate 13%) who participated, 29% used the 2006 World Health Organization Multicentre Growth Reference Study growth charts, 69% used national growth charts; 61% used software to draw growth charts and 79% did not use a formal algorithm to detect abnormal growth on growth charts. Among the 21% of paediatricians who used algorithms, many used non-algorithmic simple thresholds for height and weight and none used the algorithms published in the international literature. In all, 69% of paediatricians declared that a validated algorithm to monitor growth would be useful in daily practice. We found important between-country variations.

Conclusion: The varied growth-monitoring practices declared by primary care paediatricians reveals the need for standardization and evidence-based algorithms to define abnormal growth and the development of software that would use such algorithms.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Algorithms
  • Child
  • Cross-Sectional Studies
  • Europe
  • Growth Charts
  • Humans
  • Pediatrics / standards*
  • Physicians
  • Practice Patterns, Physicians' / standards
  • Primary Health Care / standards*
  • Reference Standards

Grants and funding

Jean-François Salaün was supported by an educational grant from the Association Française de Pédiatre Ambulaire. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There are no patents, products in development, or marketed products to declare.